SIPAI HEALTH(00314): Ren Na appointed as authorized representative.
Sino Health (00314) announced that Ms. Li Jingyi has resigned as the joint company secretary and authorized representative of the company under Rule 3.05 of the Listing Rules, effective from March 30, 2026. After Ms. Li's resignation, Ms. Ren Na will continue to serve as the company secretary independently.
SIPAI HEALTH (00314) announced that Ms. Li Jingyi has resigned as the Co-Secretary of the Company and the authorized representative of the Company under Rule 3.05 of the Listing Rules, effective from March 30, 2026. After Ms. Li's resignation, Ms. Ren Na will continue to serve as the Company Secretary independently.
Ms. Ren has been appointed as the authorized representative, effective from March 30, 2026.
Related Articles
BEAUTYFARM MED purchased 60,000 shares for 1.1492 million Hong Kong dollars on March 30th.
Chongqing Iron (01053): Hot-rolled production volume reached 4.7822 million tons in 2025.
BAOZUN-W (09991) has granted 6.1671 million restricted stock units.
BEAUTYFARM MED purchased 60,000 shares for 1.1492 million Hong Kong dollars on March 30th.
Chongqing Iron (01053): Hot-rolled production volume reached 4.7822 million tons in 2025.
BAOZUN-W (09991) has granted 6.1671 million restricted stock units.
RECOMMEND
Chinese Innovative Drug Assets Attract Major Foreign Acquisition, Cooperation Models Diversify
26/03/2026
Four Giants Subscribe As Memory Manufacturer Confirms TWD 78.718 Billion Private Placement For Capacity Expansion
26/03/2026
Year‑On‑Year Surge Exceeding 500%: Hong Kong IPOs Top HKD 100 Billion This Year
26/03/2026
